Sunshine Biopharma Stock Shoots Higher On Encouraging Data From mRNA-Based Liver Cancer Drugbenzinga.comSunshine Biopharma's K1.1 mRNA-LNP shows promise for HCC treatment in mice, while its 2024 revenue surged 45% to $34.9 million.
US Stock Futures Slip Ahead Of 'Liberation Day' Tariffs Announcement: Expert Points To Uncertainty Amid Higher Risk Premiabenzinga.comU.S. stock futures slipped on Wednesday after a mixed session on Tuesday. Futures of major benchmark indices were lower in premarket trading.
SBFM Stock Earnings: Sunshine Biopharma Misses EPS, Beats Revenue for Q2 2024investorplace.comSBFM stock results show that Sunshine Biopharma missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
7 F-Rated Growth Stocks to Avoid Right Now: June 2024investorplace.comA good rating for growth in the Portfolio Grader doesn't tell the full picture. These are all growth stocks to avoid now.
3 Penny Stocks Ready to Explode Into Dollar Signs by 2028investorplace.comThe best penny stocks to buy are those you can understand and stomach the exceptional risks of in order to profit.
SBFM Stock Earnings: Sunshine Biopharma Beats EPS, Beats Revenue for Q1 2024investorplace.comSBFM stock results show that Sunshine Biopharma beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
3 Meme Stocks to Sell That Even Roaring Kitty Can’t Saveinvestorplace.comLooking for the best meme stocks to sell after the Roaring Kitty rally? These three struggling companies seem to be beyond hope.
